CA2853343A1 - Absorbent paper and use thereof for breast cancer detection - Google Patents

Absorbent paper and use thereof for breast cancer detection Download PDF

Info

Publication number
CA2853343A1
CA2853343A1 CA2853343A CA2853343A CA2853343A1 CA 2853343 A1 CA2853343 A1 CA 2853343A1 CA 2853343 A CA2853343 A CA 2853343A CA 2853343 A CA2853343 A CA 2853343A CA 2853343 A1 CA2853343 A1 CA 2853343A1
Authority
CA
Canada
Prior art keywords
absorbent paper
cells
aspirate fluid
sample
nipple aspirate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2853343A
Other languages
English (en)
French (fr)
Inventor
Steven C. Quay
Shu-Chih Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atossa Therapeutics Inc
Original Assignee
Atossa Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atossa Genetics Inc filed Critical Atossa Genetics Inc
Publication of CA2853343A1 publication Critical patent/CA2853343A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0041—Detection of breast cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G01N33/683—Total protein determination, e.g. albumin in urine involving metal ions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G01N33/683—Total protein determination, e.g. albumin in urine involving metal ions
    • G01N33/6836—Silver staining

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2853343A 2011-10-24 2012-10-24 Absorbent paper and use thereof for breast cancer detection Abandoned CA2853343A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161550855P 2011-10-24 2011-10-24
US61/550,855 2011-10-24
PCT/US2012/061733 WO2013063147A1 (en) 2011-10-24 2012-10-24 Absorbent paper and use thereof for breast cancer detection

Publications (1)

Publication Number Publication Date
CA2853343A1 true CA2853343A1 (en) 2013-05-02

Family

ID=48168446

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2853343A Abandoned CA2853343A1 (en) 2011-10-24 2012-10-24 Absorbent paper and use thereof for breast cancer detection

Country Status (6)

Country Link
US (3) US20130130310A1 (enExample)
EP (1) EP2771686A4 (enExample)
JP (1) JP2015505359A (enExample)
CN (1) CN104040339A (enExample)
CA (1) CA2853343A1 (enExample)
WO (1) WO2013063147A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013063147A1 (en) * 2011-10-24 2013-05-02 Atossa Genetics, Inc. Absorbent paper and use thereof for breast cancer detection
US20170145515A1 (en) * 2014-06-04 2017-05-25 Atossa Genetics Inc. Molecular mammography
CN106795555B (zh) * 2014-09-02 2021-04-02 谢达斌 聚合酶连锁反应的仪器与方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3786801A (en) * 1969-02-24 1974-01-22 Diagnostic Inc Method and apparatus for aiding in the detection of breast cancer
GB8415998D0 (en) 1984-06-22 1984-07-25 Janssen Pharmaceutica Nv Staining method
JPS6294170A (ja) * 1985-10-21 1987-04-30 ピジヨン株式会社 搾乳器
US5340746A (en) * 1993-01-08 1994-08-23 Minnesota Mining And Manufacturing Company Composite reactive articles for the determination of cyanide
JPH09149890A (ja) * 1995-09-27 1997-06-10 Hisamitsu Pharmaceut Co Inc 検査用貼付剤およびその検出装置並びに検査方法
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
US6328709B1 (en) * 1998-11-13 2001-12-11 Pro Duct Health, Inc. Devices and methods to identify ductal orifices during nipple aspiration
US6629936B2 (en) 2000-05-10 2003-10-07 Cytyc Health Corporation Method and kits for differentiating breast ducts for cancer risk status
US20020013539A1 (en) 2000-07-28 2002-01-31 David Hung Methods and devices for diagnosis of precancer and cancer in breast milk ducts
US6689073B2 (en) * 2000-11-13 2004-02-10 Atossa Healthcare Inc. Methods and devices for collecting, handling and processing mammary fluid samples for evaluating breast diseases, including cancer
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
WO2003044485A2 (en) * 2001-11-20 2003-05-30 Proteex, Inc. Proteonomic methods for diagnosis and monitoring of breast cancer
US7128887B2 (en) 2003-05-29 2006-10-31 Specialty Minerals (Michigan) Inc. Platy precipitated calcium carbonate synthesis method
JP2008515871A (ja) 2004-10-07 2008-05-15 ナショナル インスティテュート オブ イミュノロジー 新規ガン関連抗体及び抗原並びにガンの診断におけるそれらの使用
WO2006062802A2 (en) * 2004-12-08 2006-06-15 Wang Paul C Device for non-surgical correction of congenital inverted nipples and/or collection of nipple aspirate fluid
WO2006128082A2 (en) * 2005-05-26 2006-11-30 The Johns Hopkins University Biomarkers for breast cancer
WO2008141318A1 (en) 2007-05-14 2008-11-20 Dr. Susan Love Research Foundation Device for determining risk of developing breast cancer and method thereof
WO2009059393A1 (en) * 2007-11-06 2009-05-14 University Health Network Method for the detection of breast cancer by determining alcam and/or bcam levels in a patient sample
CA2853351A1 (en) 2011-10-24 2013-05-02 Atossa Genetics, Inc. Method of breast cancer detection
WO2013063147A1 (en) 2011-10-24 2013-05-02 Atossa Genetics, Inc. Absorbent paper and use thereof for breast cancer detection

Also Published As

Publication number Publication date
US20130130310A1 (en) 2013-05-23
US20150323537A1 (en) 2015-11-12
CN104040339A (zh) 2014-09-10
EP2771686A4 (en) 2015-03-18
EP2771686A1 (en) 2014-09-03
WO2013063147A1 (en) 2013-05-02
US20140287430A1 (en) 2014-09-25
US9052318B2 (en) 2015-06-09
JP2015505359A (ja) 2015-02-19

Similar Documents

Publication Publication Date Title
US20250352189A1 (en) Non-invasive skin collection system
Vairo et al. Towards addressing the body electrolyte environment via sweat analysis: pilocarpine iontophoresis supports assessment of plasma potassium concentration
CA2956723C (en) System and method for monitoring health based on collected bodily fluid
Morales et al. Accuracy of self-reported tobacco use in newly diagnosed cancer patients
Mantinieks et al. The effectiveness of decontamination procedures used in forensic hair analysis
Dickson et al. The impact of differences in plasma glucose between glucose oxidase and hexokinase methods on estimated gestational diabetes mellitus prevalence
Quah et al. Patient acceptability of tear collection in the primary healthcare setting
Maestre-Batlle et al. Novel flow cytometry approach to identify bronchial epithelial cells from healthy human airways
Woud et al. Direct detection of circulating donor-derived extracellular vesicles in kidney transplant recipients
Ellett et al. Are endometrial nerve fibres unique to endometriosis? A prospective case–control study of endometrial biopsy as a diagnostic test for endometriosis in women with pelvic pain
Kuebler et al. Is stress related to the presence and persistence of oncogenic human papillomavirus infection in young women?
Frugé et al. Fingernail and toenail clippings as a non-invasive measure of chronic cortisol levels in adult cancer survivors
US9052318B2 (en) Absorbent paper and use thereof for breast cancer detection
Zhao et al. Effects of an Omaha system-based continuing nursing program on nutritional status in patients undergoing peritoneal dialysis: a randomized controlled trial
US20140255954A1 (en) Method of breast cancer detection
Bat et al. Active thrombopoiesis is associated with worse severity and activity of chronic GVHD
CN114965753A (zh) 一种lgals3bp蛋白丰度检测试剂在制备妊娠期糖尿病泪液诊断试剂中的应用
Ogbuanya et al. Diagnostic accuracy of fine needle aspiration cytology for palpable breast lumps in a Nigerian teaching hospital
Dauch et al. Three-dimensional imaging of nociceptive intraepidermal nerve fibers in human skin biopsies
CN105929168A (zh) 乳腺癌肿瘤标志物ca153的双阈值检测试纸
Huang et al. Immune dysregulation in endometrial tuberculosis: elevated HLA-G and IL-1Ra as key modulators
JP2015505359A5 (enExample)
How et al. Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients
Timilshina et al. Predictors of hemoglobin decline in non-metastatic prostate cancer patients on androgen deprivation therapy: a matched cohort study
Liu et al. Clinical significance of GRHL3 expression in diffuse large B cell lymphoma

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20171024